We present 5 exits that have taken place over the past few years as evidence of our ability to sell this company. NBM is a contract manufacturer in the biotech arena. There are 2 compelling reasons to invest: the expected ROI and our probability of success. We don't bear the risk of a single technology to be successful and we're not reliant upon the drug that we put into the vials to be approved by the FDA.